Sign InSummary
Tempest Therapeutics, Inc. has experienced a significant increase in stock price recently, but with negative earnings per share and no fundamental justification for the surge, caution is advised; however, technical analysis suggests a bullish trend and a Buy recommendation from one analyst indicates some positive momentum, making it a potential hold until the upcoming earnings announcement. (October 23, 2023)
Fundamental Analysis
Tempest Therapeutics, Inc. (Stock ticker: TPST) is a company with a market capitalization of $72.09 million. It operates on the NASDAQ stock exchange. The most recent closing price for TPST was $4.95 (as on October 23, 2023), demonstrating an appreciable increase of 6.22%.
The stock has traded between an annual high of $9.77 and an annual low of $0.17, offering an expansive price range. The volume of trading for TPST has been robust recently, with 18.9M shares changing hands; this is considerably above their average volume of 8.4M shares.
However, from an earnings perspective, the situation is somewhat less optimistic. TPST records an earnings per share (EPS) of -$2.39, which reflects a negative earnings trend. Consequently, it currently does not have a positive price-to-earnings ratio (PE).
Recent news surrounding TPST indicated a remarkable 4000% surge in the stock, without any fundamentally changing events or groundbreaking news that could justify such a dramatic upswing.
Technical Analysis
The 50-day and 200-day moving averages of TPST stand at $1.36 and $1.59 respectively. As the current stock price of $4.95 surpasses these averages, it suggests an upward momentum. However, it's worth noting the high average true range (ATR) of 26.68, indicating high price volatility.
The relative strength index (RSI) is at 63, reflecting neither overbought nor oversold conditions. The positive 3-month moving average convergence/divergence (MACD) of 1.12 also indicates a bullish trend in the short term.
The current level of support and resistance are $4.66 and $5.85 respectively. A break above resistance could pave the way for higher prices, while a breakdown below the support might signal potential downside.
The discounted cash flow (DCF) analysis suggests a value of $7.65 per share, hinting at potential undervaluation.
Expert Consensus
According to consensus estimates, one analyst recommends a "Buy" on TPST. There are neither negative sentiments nor overly positive ones, with no "Strong Buy", "Sell" or "Strong Sell" recommendations.
Stock Forecast and Evaluation
Based on the technical and fundamental analysis, for the short term, TPST might potentially experience some volatility, but the overall trend appears bullish. The company may face earnings challenges; however, the bullish trend and 'Buy' recommendation by an analyst suggest some positive momentum.
Despite this, the incredibly optimistic surge in stock price without news of fundamental improvements or achievements should be a cause for investor caution.
Given these considerations, TPST could be evaluated as a "Hold" for the time being until the upcoming earnings announcement provides a more solid basis for assessment. The stock's performance after the earnings announcement should offer valuable insights into its future trajectory.
